EdgarLookup

MACERICH CO — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that MACERICH CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
-19.4%
Profit Margin
Net income ÷ revenue
-2.4%
Return on Assets
Net income ÷ assets
2.39x
Debt-to-Equity
Total liabilities ÷ equity
+10.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.01B Feb 20, 2026
FY2025 Dec 31, 2024 $918.20M Feb 20, 2026
FY2025 Dec 31, 2023 $884.07M Feb 20, 2026
FY2024 Dec 31, 2022 $859.16M Feb 28, 2025
FY2023 Dec 31, 2021 $847.44M Feb 26, 2024
FY2020 Dec 31, 2020 $194.64M Feb 24, 2021
FY2020 Sep 30, 2020 $185.84M Feb 24, 2021
FY2020 Jun 30, 2020 $178.59M Feb 24, 2021
FY2020 Mar 31, 2020 $226.95M Feb 24, 2021
FY2020 Dec 31, 2019 $241.84M Feb 24, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($197.15M) Feb 20, 2026
FY2025 Dec 31, 2024 ($194.12M) Feb 20, 2026
FY2025 Dec 31, 2023 ($274.07M) Feb 20, 2026
FY2024 Dec 31, 2022 ($66.07M) Feb 28, 2025
FY2023 Dec 31, 2021 $14.26M Feb 26, 2024
FY2022 Dec 31, 2020 ($230.20M) Feb 24, 2023
FY2021 Dec 31, 2019 $96.82M Feb 25, 2022
FY2010 Dec 31, 2010 $25.19M Feb 25, 2011
FY2010 Dec 31, 2009 $120.74M Feb 25, 2011
FY2010 Dec 31, 2008 $166.05M Feb 25, 2011

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.37B Feb 20, 2026
FY2025 Dec 31, 2024 $8.57B Feb 20, 2026
FY2024 Dec 31, 2023 $7.51B Feb 28, 2025
FY2023 Dec 31, 2022 $8.09B Feb 26, 2024
FY2022 Dec 31, 2021 $8.35B Feb 24, 2023
FY2021 Dec 31, 2020 $9.18B Feb 25, 2022
FY2020 Dec 31, 2019 $8.85B Feb 24, 2021
FY2019 Dec 31, 2018 $9.03B Feb 25, 2020
FY2018 Dec 31, 2017 $9.61B Feb 25, 2019
FY2017 Dec 31, 2016 $9.96B Feb 23, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.84B Feb 20, 2026
FY2025 Dec 31, 2024 $5.72B Feb 20, 2026
FY2024 Dec 31, 2023 $4.99B Feb 28, 2025
FY2023 Dec 31, 2022 $5.14B Feb 26, 2024
FY2022 Dec 31, 2021 $5.17B Feb 24, 2023
FY2021 Dec 31, 2020 $6.74B Feb 25, 2022
FY2020 Dec 31, 2019 $6.02B Feb 24, 2021
FY2019 Dec 31, 2018 $5.84B Feb 25, 2020
FY2018 Dec 31, 2017 $5.64B Feb 25, 2019
FY2017 Dec 31, 2016 $5.53B Feb 23, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.45B Feb 20, 2026
FY2025 Dec 31, 2024 $2.76B Feb 20, 2026
FY2024 Dec 31, 2023 $2.45B Feb 28, 2025
FY2023 Dec 31, 2022 $2.87B Feb 26, 2024
FY2022 Dec 31, 2021 $3.05B Feb 24, 2023
FY2021 Dec 31, 2020 $2.26B Feb 25, 2022
FY2020 Dec 31, 2019 $2.63B Feb 24, 2021
FY2019 Dec 31, 2018 $2.95B Feb 25, 2020
FY2018 Dec 31, 2017 $3.68B Feb 25, 2019
FY2017 Dec 31, 2016 $4.11B Feb 23, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 20, 2026
FY2025 Dec 31, 2024 0 Feb 20, 2026
FY2025 Dec 31, 2023 (1) Feb 20, 2026
FY2024 Dec 31, 2022 0 Feb 28, 2025
FY2023 Dec 31, 2021 0 Feb 26, 2024
FY2020 Dec 31, 2020 (1) Feb 24, 2021
FY2020 Sep 30, 2020 0 Feb 24, 2021
FY2020 Jun 30, 2020 0 Feb 24, 2021
FY2020 Mar 31, 2020 0 Feb 24, 2021
FY2020 Dec 31, 2019 0 Feb 24, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 20, 2026
FY2025 Dec 31, 2024 0 Feb 20, 2026
FY2025 Dec 31, 2023 (1) Feb 20, 2026
FY2024 Dec 31, 2022 0 Feb 28, 2025
FY2023 Dec 31, 2021 0 Feb 26, 2024
FY2020 Dec 31, 2020 (1) Feb 24, 2021
FY2020 Sep 30, 2020 0 Feb 24, 2021
FY2020 Jun 30, 2020 0 Feb 24, 2021
FY2020 Mar 31, 2020 0 Feb 24, 2021
FY2020 Dec 31, 2019 0 Feb 24, 2021

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $280.25M Feb 20, 2026
FY2025 Dec 31, 2024 $89.86M Feb 20, 2026
FY2025 Dec 31, 2023 $94.94M Feb 20, 2026
FY2025 Dec 31, 2022 $100.32M Feb 20, 2026
FY2024 Dec 31, 2021 $112.45M Feb 28, 2025
FY2023 Dec 31, 2020 $465.30M Feb 26, 2024
FY2022 Dec 31, 2019 $100.01M Feb 24, 2023
FY2021 Dec 31, 2018 $102.71M Feb 25, 2022
FY2020 Dec 31, 2017 $91.04M Feb 24, 2021
FY2019 Dec 31, 2016 $94.05M Feb 25, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.07B Feb 20, 2026
FY2025 Dec 31, 2024 $4.89B Feb 20, 2026
FY2024 Dec 31, 2023 $4.14B Feb 28, 2025
FY2023 Dec 31, 2022 $4.24B Feb 26, 2024
FY2022 Dec 31, 2021 $4.42B Feb 24, 2023
FY2021 Dec 31, 2020 $4.56B Feb 25, 2022